Zymeworks Inc. — Director's Dealing 2025

Jan 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Zymeworks Inc. (ZYME)
CIK: 0001937653
Period of Report: 2025-01-10

Reporting Person: Moore Paul Andrew (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-10	Stock Option (Right to Buy)	$13.22	A	79000	Acquired	2035-01-09	Common Stock (79000)	Direct
2025-01-10	Restricted Stock Unit	$	A	53000	Acquired		Common Stock (53000)	Direct

Footnotes

F1: Stock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date.

F2: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of Issuer's common stock.

F3: RSUs vest in three equal annual installments beginning on first anniversary of grant date.